Fig. 1From: Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model a Study design including sampling time points as well as duration of levothyroxine (L-T4) treatment. b Boxplots with mean values (diamonds) of serum TSH (white) and FT4 (grey) for each time point. bas baseline, w4(T4)/w8(T4) 4 and 8 weeks of levothyroxine treatment, w12/w16 4 and 8 weeks after stopping the application pointBack to article page